Skip to main content

bit.bio's new Huntington's disease human cell model, for in vitro research and drug discovery

bit.bio’s new ioGlutamatergic Neurons HTT50CAG/WT provide a human, cell-based, in vitro model of Huntington’s Disease (HD) that accurately reflects the disease genotype. Offering industry-leading consistency and scalability, this first product from the new ioDisease Model portfolio has been developed to support key applications within drug discovery including target identification and high-throughput screening.

Brought to you bybit.bio
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

The life sciences industry is challenged by a lack of reliable, reproducible cell models that generate translatable, reflective, data of actual human disease. ioGlutamatergic Neurons HTT50CAGWTaims to provide a viable solution for HD. CRISPR/Cas9 gene editing has been used to introduce an abnormal expansion of 50 CAG repeats into the first exon of the Huntingtin gene within the wild type ioGlutamatergic Neurons. These highly characterised iPSC-derived glutamatergic neurons accurately represent the disease genotypein vitro. The engineered cells rapidly mature into functional excitatory neurons that consistently form complex neuronal structures and express typical biomarkers in as little as 11 days.

ioGlutamatergic Neurons HTT50CAGWTprovide batch-to-batch consistency at a scale of billions of cells, forming a reproducible model enabled by opti-oxTM precision reprogramming. In addition, bit.bio’s wild type ioGlutamatergic Neurons can be used as a genetically matched control for the ioGlutamatergic Neurons HTT50CAG/WT disease model, offering a physiologically-relevant isogenic pairing with which to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo